Literature DB >> 12691708

A multi-laboratory characterization of the KIR genotypes of 10th International Histocompatibility Workshop cell lines.

Mark A Cook1, Paul J Norman, Martin D Curran, Lynn D Maxwell, David C Briggs, Derek Middleton, Robert W Vaughan.   

Abstract

Killer immunoglobulinlike receptors (KIRs) are expressed on natural killer and T cells. Both inhibitory and noninhibitory forms have been described, leading to inhibition or continuation of cellular killing activity. The natural ligands identified so far of KIRs are class I human leukocyte antigens (HLA). In particular, the interaction of some KIRs with HLA-Cw has been well characterized. Recent work has implicated KIRs in affecting the outcome of hematopoietic stem-cell transplant (HSCT). This may well lead to a requirement for prospective KIR typing of donor and recipient. We have utilized different typing systems (two using polymerase chain reaction-sequence-specific primers, and one using polymerase chain reaction-sequence-specific oligonucleotide probes) in three separate laboratories to characterize the KIR gene complement of 25 cell lines from the 10th International Histocompatibility Workshop. There were consistent results in 22, and minor differences in 3. When compared with previous results for some of these cell lines, no further differences were found. The differences are due to typing of KIRs KIR2DL1 and KIR2DS5, and may be explained by technical differences or the inability to type new variants. Further improvements in typing may be required if population and clinical studies are to produce accurate results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691708     DOI: 10.1016/s0198-8859(03)00042-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations.

Authors:  Marija Velickovic; Zlatibor Velickovic; Heather Dunckley
Journal:  Immunogenetics       Date:  2006-05-30       Impact factor: 2.846

2.  High KIR diversity in Amerindians is maintained using few gene-content haplotypes.

Authors:  Ketevan Gendzekhadze; Paul J Norman; Laurent Abi-Rached; Zulay Layrisse; Peter Parham
Journal:  Immunogenetics       Date:  2006-05-05       Impact factor: 2.846

3.  Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.

Authors:  Paul J Norman; Jill A Hollenbach; Neda Nemat-Gorgani; Wesley M Marin; Steven J Norberg; Elham Ashouri; Jyothi Jayaraman; Emily E Wroblewski; John Trowsdale; Raja Rajalingam; Jorge R Oksenberg; Jacques Chiaroni; Lisbeth A Guethlein; James A Traherne; Mostafa Ronaghi; Peter Parham
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

4.  An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts.

Authors:  A Thompson; A R van der Slik; F Koning; J van Bergen
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

5.  High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.

Authors:  Kathleen A Houtchens; Robert J Nichols; Martha B Ladner; Hannah E Boal; Cristina Sollars; Daniel E Geraghty; Lee M Davis; Peter Parham; Elizabeth A Trachtenberg
Journal:  Immunogenetics       Date:  2007-04-27       Impact factor: 2.846

6.  KIR gene diversity in Mexican mestizos of San Luis Potosí.

Authors:  Diana Lorena Alvarado-Hernández; Daniel Hernández-Ramírez; Daniel Ernesto Noyola; Christian Alberto García-Sepúlveda
Journal:  Immunogenetics       Date:  2011-06-04       Impact factor: 3.330

7.  Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study.

Authors:  Brian Brestovac; Michelle E Wong; Raymond Tjendera; Paul J Costantino; Cyril Mamotte; Campbell S Witt
Journal:  Infect Agent Cancer       Date:  2013-09-06       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.